跳到正文
原文
NEJM· @NEJM · X·· 23 天前AI 评分42
AI 导读

小细胞肺癌是全球最具侵袭性和致死性的癌症之一。尽管治疗已改善总生存期,但多数患者最终仍出现疾病进展。一段新的 Quick Take 视频总结了 3 期 TAISHAN-302 试验的研究结果。https://nej.md/4hZz1CY

正文

Small-cell lung cancer is one of the most aggressive and lethal cancers worldwide. Although treatments have improved overall survival, most patients ultimately have disease progression. Research findings from the phase 3 TAISHAN-302 trial are summarized in a new Quick Take video. https://nej.md/4hZz1CY

来源:NEJM · x.com